PATHOPHYSIOLOGY OF ITCHING

Citation
Mw. Greaves et Pd. Wall, PATHOPHYSIOLOGY OF ITCHING, Lancet, 348(9032), 1996, pp. 938-940
Citations number
30
Categorie Soggetti
Medicine, General & Internal
Journal title
LancetACNP
ISSN journal
01406736
Volume
348
Issue
9032
Year of publication
1996
Pages
938 - 940
Database
ISI
SICI code
0140-6736(1996)348:9032<938:POI>2.0.ZU;2-5
Abstract
Itching is the predominant symptom of skin disease but it is ill-under stood and a challenge for future research. Even the major nerve pathwa ys for itch, and its relationship to pain are debatable. In inflamed s kin, histamine plays a major role and its mode of release from mast ce lls in, for example, chronic urticaria is now better appreciated. Tach ykinins including substance P and cytokines including interleukin-2 ar e evidently important peripherally. Opioid mu-receptor-dependent proce sses activate inhibitory circuits in the central nervous system and re gulate the extent of intensity and quality of perceived itch. It is pr oposed that stimulation of large areas of skin such as by scratching, generates inhibitory activity which suppresses itch excitation. Therap eutic intervention based upon understanding these regulatory processes is a real prospect.